H.J. Ochel
Medical Faculty
Clinic for Radiation Therapy
Otto-von-Guericke-University
Magdeburg
Germany
Name/email consistency: high
- A simple measure of reliability in clinical trials of surgical adjuvant radiotherapy. Ochel, H.J. Eur. J. Surg. Oncol (2006)
- In vitro combined modality treatment of prostate carcinoma cells with 17-(allylamino)-17-demethoxygeldanamycin and ionizing radiation. Ochel, H.J., Gademann, G. Anticancer Res. (2006)
- Characterization of the combined cellular survival effects of benzoquinone-ansamycins and ionizing radiation. Ochel, H.J., Gademann, G. J. Cancer Res. Clin. Oncol. (2005)
- Effects of imatinib mesylate on adenoid cystic carcinomas. Ochel, H.J., Gademann, G., Röcken, C., Wördehoff, H. Anticancer Res. (2005)
- Correlation between crystal violet dissolution assay and manual colony counting on the in vitro effects of Hsp90-inhibitors. Ochel, H.J. J. Exp. Ther. Oncol. (2005)
- A proposal for the repositioning of prophylactic breast radiotherapy of prostate cancer patients. Ochel, H.J. Future. Oncology. (london,. England) (2005)
- Destabilization of the non-pathogenic, cellular prion-protein by a small molecular drug. Ochel, H.J., Gademann, G. Antivir. Ther. (Lond.) (2004)
- Modulation of prion protein structural integrity by geldanamycin. Ochel, H.J., Gademann, G., Trepel, J., Neckers, L. Glycobiology (2003)
- Heat-shock protein 90: potential involvement in the pathogenesis of malignancy and pharmacological intervention. Ochel, H.J., Gademann, G. Onkologie (2002)
- Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones. Ochel, H.J., Eichhorn, K., Gademann, G. Cell. Stress. Chaperones (2001)